Furthermore, Western blot analysis demonstrated that DM-AKG treatment significantly reduced the expression of KIM-1 and Caspase-3 in the cells compared to CIS-treated HK-2 cells (all p < 0.05) (Fig. 1c). The gene discussed is CASP3; the disease is in situ carcinoma.